Pulike Biological Engineering Strategic Asset Allocation Index
Pulike Biological Engineering strategic asset allocation index. Pulike Biological Engineering (603566) has a Strategic Asset Allocation Index of 37.6% as of June 2023. Strategic assets (PP&E of CN¥1.05 Billion plus long-term investments of CN¥-) total CN¥1.05 Billion, measured against net assets of CN¥2.79 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Pulike Biological Engineering balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Pulike Biological Engineering (2012–2021)
Strategic asset allocation index of Pulike Biological Engineering from 2012 to 2021. This chart shows how Pulike Biological Engineering's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of June 2023, the index stands at 37.6%, representing strategic assets of CN¥1.05 Billion against net assets of CN¥2.79 Billion CNY. Check tangible equity quality of Pulike Biological Engineering to evaluate the tangible quality of the company's equity base.
Pulike Biological Engineering Strategic Asset Allocation Index by Year (2012–2021)
Pulike Biological Engineering strategic asset allocation index by year from 2012 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Pulike Biological Engineering from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Pulike Biological Engineering market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 36.2% | CN¥651.60 Million | CN¥651.60 Million | CN¥- | CN¥1.80 Billion | ▲ +9.0 pp |
| 2020 | 27.2% | CN¥465.61 Million | CN¥465.61 Million | CN¥- | CN¥1.71 Billion | ▲ +3.4 pp |
| 2019 | 23.8% | CN¥395.37 Million | CN¥395.37 Million | CN¥- | CN¥1.66 Billion | ▼ -16.4 pp |
| 2018 | 40.2% | CN¥657.54 Million | CN¥367.36 Million | CN¥290.17 Million | CN¥1.64 Billion | ▲ +12.9 pp |
| 2017 | 27.3% | CN¥427.82 Million | CN¥369.28 Million | CN¥58.53 Million | CN¥1.57 Billion | ▲ +1.9 pp |
| 2016 | 25.4% | CN¥375.85 Million | CN¥333.52 Million | CN¥42.33 Million | CN¥1.48 Billion | ▲ +3.1 pp |
| 2015 | 22.2% | CN¥297.41 Million | CN¥290.73 Million | CN¥6.68 Million | CN¥1.34 Billion | ▼ -20.8 pp |
| 2014 | 43.0% | CN¥294.17 Million | CN¥294.17 Million | CN¥- | CN¥683.59 Million | ▼ -5.5 pp |
| 2013 | 48.6% | CN¥293.09 Million | CN¥293.09 Million | CN¥- | CN¥603.33 Million | ▲ +7.3 pp |
| 2012 | 41.3% | CN¥181.85 Million | CN¥181.85 Million | CN¥- | CN¥440.47 Million | — |